Industry News
Project To Improve Molecular Diagnosis Of Lynch Syndrome
Jun 27, 2013
The Fundacion Mutua Madrilena, in its 10th Call for Aids to Research, has selected a project to improve the diagnosis of Lynch syndrome led by researcher Marta Pineda, from the Hereditary Cancer research group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO). The aid is provided with 33,000 euros and has a duration of two years... Read More
UK Lags Behind EU Counterparts In Uptake Of Oncology Biomarker Testing
Jun 27, 2013
Research reveals that the uptake of diagnostic testing amongst cancer patients in the UK trails behind that of other Western European markets... Read More
Nitric Oxide Repletion Of Stored Blood Improves Post-Procedural Outcomes
Jun 27, 2013
Researchers from Case Western Reserve University School of Medicine have developed an unprecedented approach to restore nitric oxide (NO) to donated blood, a breakthrough that could dramatically reduce harmful effects from transfusions... Read More
Aspirin's Preventive Colon Cancer Effect Depends On Genes
Jun 27, 2013
Taking a daily dose of aspirin helps lower the risk of colon cancer. However, a new study has found that the reduced risk of colorectal cancer is affected by a mutation of a gene called BRAF. Colon cancer is a leading cause of cancer-related death worldwide. In 2008, there were 1.23 million new clinically diagnosed cases of colorectal cancer; over 608,000 people died from the disease that year... Read More
Heart Failure Survivors At Increased Cancer Risk
Jun 27, 2013
Heart failure patients are surviving more often with the heart condition but they are increasingly more likely to be diagnosed with cancer, a trend that could be attributed to increased surveillance, side effects of treatments, or other causes, according to a study published online in the Journal of the American College of Cardiology... Read More
Gene Transfer May Play Role In Cancer, Other Diseases Linked With DNA Damage
Jun 27, 2013
Bacterial DNA may integrate into the human genome more readily in tumors than in normal human tissue, scientists have found. The researchers, affiliated with the University of Maryland School of Medicine's Institute for Genome Sciences, analyzed genomic sequencing data available from the Human Genome Project, the 1,000 Genomes Project and The Cancer Genome Atlas... Read More
After Lumpectomy For Breast Cancer, Rural Women Less Likely To Get Radiation Therapy
Jun 27, 2013
Rural women with breast cancer are less likely than their urban counterparts to receive recommended radiation therapy after having a lumpectomy, a breast-sparing surgery that removes only tumors and surrounding tissue, a study by Mayo Clinic and others found. The difference is one of several rural disparities in breast cancer diagnosis and treatment the researchers discovered... Read More
NICE Final Guidance On Blood Cancer Drug Jakavi™ (ruxolitinib) Delivers Major Setback For Myelofibrosis Patients
Jun 26, 2013
The only therapy available for a disease with a clear unmet medical need will not be made available to UK patients Novartis today expressed disappointment at the National Institute for Health and Clinical Excellence's (NICE) decision to publish final guidance not recommending ruxolitinib (INC424, Jakavi™) for the treatment of disease-related splenomegaly (enlarged spleen... Read More
Xtandi™ (Enzalutamide) Authorised In The European Union (EU) For Advanced Prostate Cancer
Jun 26, 2013
Enzalutamide authorised in European Union (EU) for the treatment of adult men with metastatic castrationresistant prostate cancer whose disease has progressed on or after docetaxel therapy[1] Astellas Pharma Europe Ltd., the European Headquarters of Tokyobased Astellas Pharma Inc. (TSE:4503), and Medivation, Inc... Read More
Helping RNA Escape From Cells' Recycling Process Could Make It Easier To Shut Off Disease-Causing Genes
Jun 26, 2013
Nanoparticles that deliver short strands of RNA offer a way to treat cancer and other diseases by shutting off malfunctioning genes. Although this approach has shown some promise, scientists are still not sure exactly what happens to the nanoparticles once they get inside their target cells... Read More
Previous Page Next Page